Structural Formula (Olinvyk 1)
Olinvyk Injection, Solution
Product Images NDC 71308-021
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Olinvyk (NDC 71308-021). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Trevena, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Olinvyk 2)
This is a graph that shows the average pain score over a period of time, measured in hours. The treatment options include Placebo, OLINVYK 0.35mg, OLINVYK 0.5mg, and Morphine. The pain score appears to increase over time for all treatments, with the highest score being 10 and the lowest being 0. It is not clear what the units for %2, E3, and @ represent in this context.*
Figure 2 (Olinvyk 3)
The text is a table showing the average pain score at different time intervals for different treatments. The treatments include a placebo, two doses of OLINVYK (35mg and 50mg), and morphine.*
1 mg/ml (Vial Label)
1 mg/ml (Carton Label)
This is a description of a pharmaceutical product called Olinvyk® (oliceridine) injection. The carton contains ten vials of 1 mg/mL solution for intravenous use only. The medication may be habit-forming and harmful if given to someone for whom it was not prescribed. The GTIN (Global Trade Item Number) is 0037130801105. The product should be stored at 20-25°C and protected from freezing and light. The vials contain oliceridine, L-histcine, and mannitol in water or injection, and there are no preservatives in the solution. Dosage should be determined by prescribing information.*
2 mg/2 mL (Vial Label)
This is a description of a medication identified by its National Drug Code (NDC) 71308-021-01. The medication is called Olinvyk and is administered through injection. It contains 2mg of active ingredients per 2mL (1mg/mL) of solution. The additional text "PC5076B" and "olcendlne" are not clear or relevant in identifying the medication.*
2 mg/ 2 mL (Carton Label)
This text appears to be a combination of various information about a medication that is contained in a carton. It lists important details including the drug name (cliceridine), its dosage, the warnings and precautions to be taken, its ingredients, as well as the carton's content and format. It also includes a barcode and a 2D matrix code.*
30 mg/30 mL (Vial Label)
Olinvyk is a prescription medication that is available as an injection. The medication comes in a single-patient-use vial with 30mg per 30mL solution. It contains an active ingredient called "oliceridine." This medication is intended for the administration of PCA use only and is meant for intravenous use. Unused portion should be discarded.*
30 mg/ 30 mL (Carton Label)
This text seems to be a combination of medical prescriptions and warnings. It includes dosage information for an injection that contains Codeine, and recommended storage and temperature conditions. It also includes warnings that the medication may be harmful if given to someone for whom it was not prescribed and may be habit-forming. The text also indicates that this is a single-patient-use medication and should only be used intravenously.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
